Last update 17 Apr 2025

CC-12507(Celgene Corp.)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CC-125007, CC-12507
Target
CDKN1B x Ubiquitin-protein ligases
Action
inhibitors
Mechanism
CDKN1B inhibitors(cyclin dependent kinase inhibitor 1B inhibitors), Ubiquitin ligase inhibitors(E3 ubiquitin ligase components inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Multiple Myeloma
Originator Organization
Celgene Corp.Celgene Corp.
Active Organization-
Inactive Organization
Celgene Corp.Celgene Corp.The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CC-12507(Celgene Corp.)
Login to view more data
100 Translational Medicine associated with CC-12507(Celgene Corp.)
Login to view more data
100 Patents (Medical) associated with CC-12507(Celgene Corp.)
Login to view more data
100 Deals associated with CC-12507(Celgene Corp.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaDiscovery
United States
The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
16 Nov 2006
Multiple MyelomaDiscovery
United States
Celgene Corp.Celgene Corp.
16 Nov 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free